Skip to main content
. 2023 Jun 15;12(6):1049. doi: 10.3390/antibiotics12061049

Table 5.

Quality of life of participants at each follow-up as evaluated by SF-36 questionnaire.

Results Baseline
Mean ± SD
6 Weeks
Mean ± SD
12 Weeks
Mean ± SD
24 Weeks
Mean ± SD
Physical health 37.14 ± 4.23 47.94 ± 14.77 # 55.51 ± 13.78 # 60.63 ± 14.64 #
 Physical functioning 46.86 ± 26.10 50.49 ± 26.91 63.98 ± 26.12 # 72.93 ± 23.49 #
 Role-physical 5.27 ± 8.14 11.52 ± 10.71 # 14.29 ± 10.67 # 16.98 ± 9.65 #
 Bodily pain 46.96 ± 26.56 64.39 ± 20.34 # 73.47 ± 18.29 # 78.89 ± 19.95 #
 General health 49.45 ± 19.50 65.35 ± 17.69 # 70.31 ± 16.84 # 73.72 ± 17.99 #
Mental health 47.44 ± 17.48 58.99 ± 14.12 # 64.81 ± 12.83 # 67.21 ± 13.63 #
 Vitality 66.79 ± 24.48 80.76 ± 21.24 87.88 ± 19.53 # 91.44 ± 20.89 #
 Social function 56.62 ± 25.54 67.40 ± 20.78 75.00 ± 19.09 # 80.16 ± 19.82 #
 Role- emotional 7.35 ± 9.67 15.03 ± 10.41 # 17.01 ± 10.06 # 18.12 ± 10.14 #
 Mental health 58.98 ± 21.99 72.78 ± 14.24 # 79.35 ± 12.09 # 79.13 ± 13.38 #

# Denoted significantly different compared to the baseline values, p < 0.1.